Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
B-Cell Depleting Drug Shows Benefit in IgG-Related Disease
WASHINGTON — The B-cell depleting agent inebilizumab (Uplizna) dramatically reduced the risk of flares and increased year-long remission of IgG4-related disease (RD), new research has found. In a phase 3, multicenter, double-blind, randomized, placebo-controlled trial of 135 adults with active…
English